These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 37284510)

  • 21. COVID-19 vaccine acceptance and its socio-demographic and emotional determinants: A multi-country cross-sectional study.
    de Figueiredo A; Simas C; Larson HJ
    Vaccine; 2023 Jan; 41(2):354-364. PubMed ID: 36414475
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Post COVID-19 vaccination side effects and associated factors among vaccinated health care providers in Oromia region, Ethiopia in 2021.
    Segni MT; Demissie HF; Adem MK; Geleto AK; Kelkile MW; Sori BK; Heyi ML; Iticha DG; Bejiga GS; Guddisa AB; Sima YA; Amente LT; Bayisa DA; Hurisa MB; Jiru TK
    PLoS One; 2022; 17(12):e0278334. PubMed ID: 36480564
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Attitudes Toward COVID-19 Illness and COVID-19 Vaccination among Pregnant Women: A Cross-Sectional Multicenter Study during August-December 2020.
    Battarbee AN; Stockwell MS; Varner M; Newes-Adeyi G; Daugherty M; Gyamfi-Bannerman C; Tita AT; Vorwaller K; Vargas C; Subramaniam A; Reichle L; Galang RR; Powers E; Lucca-Susana M; Parks M; Chen TJ; Razzaghi H; Dawood FS
    Am J Perinatol; 2022 Jan; 39(1):75-83. PubMed ID: 34598291
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial.
    Akova M; Unal S
    Trials; 2021 Apr; 22(1):276. PubMed ID: 33849629
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Determinants of COVID-19 immunisation uptake in a country with high mortality and a low vaccination rate.
    Aksentijevic D; Tanner R; Lazović-Pita L; Peštek A; Abdić A
    J Infect Public Health; 2023 Aug; 16(8):1322-1331. PubMed ID: 37343504
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Caregivers' intentions to COVID-19 vaccination for their children in China: a cross-sectional survey.
    Feng H; Zhu H; Zhang H; Cao L; Li L; Wang J; Huang Y; Lai X; Lyu Y; Jing R; Guo J; Yin Z; Fang H
    Hum Vaccin Immunother; 2021 Dec; 17(12):4799-4805. PubMed ID: 34756123
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Knowledge, attitudes, and perceptions of COVID-19 vaccine and refusal to receive COVID-19 vaccine among healthcare workers in northeastern Ethiopia.
    Adane M; Ademas A; Kloos H
    BMC Public Health; 2022 Jan; 22(1):128. PubMed ID: 35042476
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Acceptance of SARS-CoV-2 vaccination and the associated factors among dental health care professionals: A cross-sectional survey.
    Qabool H; Hamid F; Sukhia RH
    Dent Med Probl; 2022; 59(1):21-26. PubMed ID: 35138698
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Risk and symptoms of COVID-19 in health professionals according to baseline immune status and booster vaccination during the Delta and Omicron waves in Switzerland-A multicentre cohort study.
    Babouee Flury B; Güsewell S; Egger T; Leal O; Brucher A; Lemmenmeier E; Meier Kleeb D; Möller JC; Rieder P; Rütti M; Schmid HR; Stocker R; Vuichard-Gysin D; Wiggli B; Besold U; McGeer A; Risch L; Friedl A; Schlegel M; Kuster SP; Kahlert CR; Kohler P;
    PLoS Med; 2022 Nov; 19(11):e1004125. PubMed ID: 36342956
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The coverage of SARS-CoV-2 vaccination and the willingness to receive the SARS-CoV-2 variant vaccine among employees in China.
    Zhang XR; Li ZJ; Fu Q; Wang JD; Huang QM; Song WQ; Xu XY; Li ZH; Mao C
    BMC Public Health; 2023 Mar; 23(1):542. PubMed ID: 36949421
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Willingness to Be Vaccinated against COVID-19 in Spain before the Start of Vaccination: A Cross-Sectional Study.
    Rodríguez-Blanco N; Montero-Navarro S; Botella-Rico JM; Felipe-Gómez AJ; Sánchez-Más J; Tuells J
    Int J Environ Res Public Health; 2021 May; 18(10):. PubMed ID: 34063476
    [TBL] [Abstract][Full Text] [Related]  

  • 32. COVID-19 vaccine acceptance among cold-chain workers in Shenzhen, China: A cross-sectional survey.
    Liu L; Zhang M; Chen H; Xian J; Cao H; Zhou X; Gu Z; Liu H; Li Q; Wu F; Chen Q; Lin Q
    Hum Vaccin Immunother; 2022 Nov; 18(5):2056400. PubMed ID: 35468306
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effectiveness of BNT162b2 and CoronaVac COVID-19 vaccination against asymptomatic and symptomatic infection of SARS-CoV-2 omicron BA.2 in Hong Kong: a prospective cohort study.
    Tsang NNY; So HC; Cowling BJ; Leung GM; Ip DKM
    Lancet Infect Dis; 2023 Apr; 23(4):421-434. PubMed ID: 36521506
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vaccination coverage among COVID-19 prevention and control management teams at primary healthcare facilities in China and their attitudes towards COVID-19 vaccine: a cross-sectional online survey.
    Yan YY; Wang HT; Fan TY; Sun XJ; Du ZH; Sun XM
    BMJ Open; 2022 Apr; 12(4):e056345. PubMed ID: 35393315
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association Between Vaccination With BNT162b2 and Incidence of Symptomatic and Asymptomatic SARS-CoV-2 Infections Among Health Care Workers.
    Angel Y; Spitzer A; Henig O; Saiag E; Sprecher E; Padova H; Ben-Ami R
    JAMA; 2021 Jun; 325(24):2457-2465. PubMed ID: 33956048
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intention to vaccinate against COVID-19 and adherence to non-pharmaceutical interventions against COVID-19 prior to the second wave of the pandemic in Uganda: a cross-sectional study.
    Wafula ST; Mugume IB; Sensasi B; Okware S; Chimbaru A; Nanyunja M; Talisuna A; Kabanda R; Bakyaita T; Wanyenze RK; Byakika-Tusiime J
    BMJ Open; 2022 Jun; 12(6):e057322. PubMed ID: 35654469
    [TBL] [Abstract][Full Text] [Related]  

  • 37. SARS-CoV-2 variants and the global pandemic challenged by vaccine uptake during the emergence of the Delta variant: A national survey seeking vaccine hesitancy causes.
    AlJamaan F; Temsah MH; Alhasan K; Alenezi S; Alhaboob A; Alrabiaah A; Batais M; Alshahrani F; Assiri RA; Bafaqih H; Alaraj A; Al Qadrah B; Alhaidary A; Saad K; Saddik B; Halwani R; Rabaan AA; Al-Subaie S; Barry M; Al-Tawfiq JA
    J Infect Public Health; 2022 Jul; 15(7):773-780. PubMed ID: 35728424
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Safety of COVID-19 vaccines in pregnancy: a Canadian National Vaccine Safety (CANVAS) network cohort study.
    Sadarangani M; Soe P; Shulha HP; Valiquette L; Vanderkooi OG; Kellner JD; Muller MP; Top KA; Isenor JE; McGeer A; Irvine M; De Serres G; Marty K; Bettinger JA;
    Lancet Infect Dis; 2022 Nov; 22(11):1553-1564. PubMed ID: 35964614
    [TBL] [Abstract][Full Text] [Related]  

  • 39. COVID-19 vaccine hesitancy and refusal and associated factors in an adult population in Saskatchewan, Canada: Evidence from predictive modelling.
    Muhajarine N; Adeyinka DA; McCutcheon J; Green KL; Fahlman M; Kallio N
    PLoS One; 2021; 16(11):e0259513. PubMed ID: 34767603
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effectiveness of BNT162b2 vaccine against SARS-CoV-2 infection and severe COVID-19 in children aged 5-11 years in Italy: a retrospective analysis of January-April, 2022.
    Sacco C; Del Manso M; Mateo-Urdiales A; Rota MC; Petrone D; Riccardo F; Bella A; Siddu A; Battilomo S; Proietti V; Popoli P; Menniti Ippolito F; Palamara AT; Brusaferro S; Rezza G; Pezzotti P; Fabiani M;
    Lancet; 2022 Jul; 400(10346):97-103. PubMed ID: 35780801
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.